In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...
In a report released today, Liam Schofield from Morgans maintained a Buy rating on MAAS Group Holdings Ltd. (MGH – Research Report), with a ...
Curaleaf, a provider of consumer cannabis products, introduced the latest addition to its new line of hemp-derived THC products: Select Zero Proof 2.5 mg Seltzer.